# NEWMONT Corp: overview

NEM · NYSE · CIK 1164727 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nem.md) · [Financials](/companies/nem/financials.md) · [Filings](/companies/nem/filings.md) · [Insiders](/companies/nem/insiders.md)

Latest reported revenue: [$6.36bn](/filings/0001164727-26-000043.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 22, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001164727-26-000043).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,652 d](/filings/0001164727-26-000010.md) | [5,010](/filings/0001164727-26-000019.md) | [5,317](/filings/0001164727-26-000036.md) | [5,524](/filings/0001164727-26-000043.md) | [6,818 d](/filings/0001164727-26-000010.md) | [7,307](/filings/0001164727-26-000019.md) | [6,118](/filings/0001164727-26-000036.md) | [6,363](/filings/0001164727-26-000043.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [24.8% d](/filings/0001164727-26-000010.md) | [37.7%](/filings/0001164727-26-000019.md) | [38.8%](/filings/0001164727-26-000036.md) | [33.2%](/filings/0001164727-26-000043.md) | [19.1% d](/filings/0001164727-26-000010.md) | [44.6%](/filings/0001164727-26-000019.md) | [36.0%](/filings/0001164727-26-000036.md) | [38.9%](/filings/0001164727-26-000043.md) |
| Diluted EPS | $ per share | not reported | [1.68](/filings/0001164727-26-000019.md) | [1.85](/filings/0001164727-26-000036.md) | [1.67](/filings/0001164727-26-000043.md) | not reported | [3.00](/filings/0001164727-26-000019.md) | [2.06](/filings/0001164727-26-000036.md) | [2.35](/filings/0001164727-26-000043.md) |
| Free cash flow | $m | [1,636 d](/filings/0001164727-26-000010.md) | [1,205](/filings/0001164727-26-000019.md) | [1,710 d](/filings/0001164727-26-000036.md) | [1,571 d](/filings/0001164727-26-000043.md) | [2,813 d](/filings/0001164727-26-000010.md) | [3,144](/filings/0001164727-26-000019.md) | [2,205 d](/filings/0001164727-26-000036.md) | [1,912 d](/filings/0001164727-26-000043.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.2](/filings/0001164727-24-000016.md) | [11.9](/filings/0001164727-25-000011.md) | [11.8](/filings/0001164727-26-000010.md) | [18.7](/filings/0001164727-26-000010.md) | [22.7](/filings/0001164727-26-000010.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [9.5%](/filings/0001164727-24-000016.md) | [(3.6%)](/filings/0001164727-25-000011.md) | [(21.1%)](/filings/0001164727-26-000010.md) | [17.9%](/filings/0001164727-26-000010.md) | [31.3%](/filings/0001164727-26-000010.md) |
| Diluted EPS | $ per share | [1.46](/filings/0001164727-24-000016.md) | [(0.54)](/filings/0001164727-25-000011.md) | [(2.97)](/filings/0001164727-26-000010.md) | [2.92](/filings/0001164727-26-000010.md) | [6.39](/filings/0001164727-26-000010.md) |
| Free cash flow | $bn | [2.6](/filings/0001164727-24-000016.md) | [1.1](/filings/0001164727-25-000011.md) | [0.1](/filings/0001164727-26-000010.md) | [3.0](/filings/0001164727-26-000010.md) | [7.3](/filings/0001164727-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/nem/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $11.29bn | 120,875,298 |  | Reduced −5,207,318 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.51bn | 69,663,282 |  | Reduced −1,063,510 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.89bn | 52,396,702 |  | Added +1,565,716 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $3.60bn | 38,580,784 |  | Added +774,044 |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $3.00bn | 32,114,698 |  | Reduced −3,883,894 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.69bn | 27,976,177 |  | Reduced −288,848 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $1.86bn | 19,964,283 |  | Added +467,416 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $1.63bn | 17,442,460 |  | Added +2,872,870 |
| [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $1.34bn | 14,348,997 |  | New +14,348,997 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $1.22bn | 13,056,801 |  | Added +818,861 |

## Recent filings

[All 2,175 filings](/companies/nem/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:46 ET | [10-Q](/filings/0001164727-26-000043.md) | Quarterly report, period 2026-09-30 | 0001164727-26-000043 |
| 2026-10-22 | 20:05 ET | [8-K](/filings/0001164727-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001164727-26-000041 |
| 2026-08-20 | 20:17 ET | [8-K](/filings/0001104659-26-099237.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-099237 |
| 2026-08-13 | 20:31 ET | [8-K](/filings/0001104659-26-095968.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-095968 |
| 2026-07-23 | 20:46 ET | [10-Q](/filings/0001164727-26-000036.md) | Quarterly report, period 2026-06-30 | 0001164727-26-000036 |
| 2026-07-23 | 20:05 ET | [8-K](/filings/0001164727-26-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001164727-26-000034 |
| 2026-06-15 | 21:20 ET | [8-K](/filings/0001104659-26-074137.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-074137 |
| 2026-05-13 | 20:17 ET | [8-K](/filings/0001104659-26-060260.md) | 5.07 Shareholder vote results | 0001104659-26-060260 |
| 2026-04-28 | 20:15 ET | [8-K](/filings/0001104659-26-050355.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-050355 |
| 2026-04-23 | 20:31 ET | [10-Q](/filings/0001164727-26-000019.md) | Quarterly report, period 2026-03-31 | 0001164727-26-000019 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001164727-26-000010.md), filed Feb 19, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1164727
- Tickers: NEM, NEMCL
- Exchange: NYSE
- SIC code: 1040 Gold and Silver Ores
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.